The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis

BORA İ. E., Akdede B. B., ALPTEKİN K.

PSYCHOLOGICAL MEDICINE, vol.47, no.6, pp.1030-1040, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 47 Issue: 6
  • Publication Date: 2017
  • Doi Number: 10.1017/s0033291716003366
  • Journal Name: PSYCHOLOGICAL MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Page Numbers: pp.1030-1040
  • Keywords: Cognition, diabetes mellitus, dyslipidemia, hypertension, metabolic syndrome, obesity, schizophrenia, CLINICAL ANTIPSYCHOTIC TRIALS, TYPE-2 DIABETES-MELLITUS, ULTRA-HIGH RISK, 1ST-EPISODE PSYCHOSIS, DEFICITS, OBESITY, HYPERTENSION, ASSOCIATION, PREVALENCE, NEUROCOGNITION
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background. Individuals with schizophrenia are at greater risk for metabolic syndrome (MetS) which is associated with cognitive deficits in the general population. MetS might be potentially an important contributing factor to cognitive impairment in schizophrenia.